Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Erben P

Collect these papers and discover other ones on Labmeeting. Learn more.

Sustained molecular response with interferon alfa maintenance after induction therapy with imatinib plus interferon alfa in patients with chronic myeloid leukemia.

+ cite this

+ View Abstract

Burchert A, Müller MC, Kostrewa P, Erben P, Bostel T, Liebler S, Hehlmann R, Neubauer A, and Hochhaus A

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 28(8):1429-35, 2010 Mar 10 - Who cited this? | PubMed ID: 20142590 | Fulltext

TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals.

+ cite this

+ View Abstract

Chase A, Ernst T, Fiebig A, Collins A, Grand F, Erben P, Reiter A, Schreiber S, and Cross NC

Haematologica 95(1):20-6, 2010 Jan - Who cited this? | PubMed ID: 19797732 | Fulltext

Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations.

+ cite this

+ View Abstract

Müller MC, Cortes JE, Kim DW, Druker BJ, Erben P, Pasquini R, Branford S, Hughes TP, Radich JP, Ploughman L, Mukhopadhyay J, and Hochhaus A

Blood 114(24):4944-53, 2009 Dec 3 - Who cited this? | PubMed ID: 19779040 | Fulltext

Harmonization of molecular monitoring of CML therapy in Europe.

+ cite this

+ View Abstract

Müller MC, Cross NC, Erben P, Schenk T, Hanfstein B, Ernst T, Hehlmann R, Branford S, Saglio G, and Hochhaus A

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 23(11):1957-63, 2009 Nov - Who cited this? | PubMed ID: 19710700 | Fulltext

Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase.

+ cite this

+ View Abstract

Hughes T, Saglio G, Branford S, Soverini S, Kim DW, Müller MC, Martinelli G, Cortes J, Beppu L, Gottardi E, Kim D, Erben P, Shou Y, Haque A, Gallagher N, Radich J,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(25):4204-10, 2009 Sep 1 - Who cited this? | PubMed ID: 19652056 | Fulltext

Cause and management of therapy resistance.

+ cite this

+ View Abstract

Hochhaus A, Schenk T, Erben P, Ernst T, La Rosée P, and Müller MC

Best practice & research. Clinical haematology 22(3):367-79, 2009 Sep - Who cited this? | PubMed ID: 19959087 | Fulltext

Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial.

+ cite this

+ View Abstract

Horisberger K, Treschl A, Mai S, Barreto-Miranda M, Kienle P, Ströbel P, Erben P, Woernle C, Dinter D, Kähler G, Hochhaus A, Post S, Willeke F, Wenz F, Hofheinz RD, and MARGIT (Mannheimer Arbeitsgruppe für Gastrointestinale Tumoren)

International journal of radiation oncology, biology, physics 74(5):1487-93, 2009 Aug 1 - Who cited this? | PubMed ID: 19131187 | Fulltext

Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial.

+ cite this

+ View Abstract

Apperley JF, Cortes JE, Kim DW, Roy L, Roboz GJ, Rosti G, Bullorsky EO, Abruzzese E, Hochhaus A, Heim D, de Souza CA, Larson RA, Lipton JH, Khoury HJ, Kim HJ, Sillaber C,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(21):3472-9, 2009 Jul 20 - Who cited this? | PubMed ID: 19487385 | Fulltext

Topoisomerase I expression correlates to response to neoadjuvant irinotecan-based chemoradiation in rectal cancer.

+ cite this

+ View Abstract

Horisberger K, Erben P, Muessle B, Woernle C, Stroebel P, Kaehler G, Wenz F, Hochhaus A, Post S, Willeke F, Hofheinz RD, and MARGIT (Mannheimer Arbeitsgruppe für Gastrointestinale Tumoren)

Anti-cancer drugs 20(6):519-24, 2009 Jul - Who cited this? | PubMed ID: 19436196 | Fulltext

Identification of a MYO18A-PDGFRB fusion gene in an eosinophilia-associated atypical myeloproliferative neoplasm with a t(5;17)(q33-34;q11.2).

+ cite this

+ View Abstract

Walz C, Haferlach C, Hänel A, Metzgeroth G, Erben P, Gosenca D, Hochhaus A, Cross NC, and Reiter A

Genes, chromosomes & cancer 48(2):179-83, 2009 Feb - Who cited this? | PubMed ID: 19006078 | Fulltext

The molecular anatomy of the FIP1L1-PDGFRA fusion gene.

+ cite this

+ View Abstract

Walz C, Score J, Mix J, Cilloni D, Roche-Lestienne C, Yeh RF, Wiemels JL, Ottaviani E, Erben P, Hochhaus A, Baccarani M, Grimwade D, Preudhomme C, Apperley J, Martinelli G, Saglio G,

(show remaining authors)

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 23(2):271-8, 2009 Feb - Who cited this? | PubMed ID: 18987651 | Fulltext

mRNA Expression of Platelet-Derived Growth Factor Receptor-beta and C-KIT: Correlation With Pathologic Response to Cetuximab-Based Chemoradiotherapy in Patients With Rectal Cancer.

+ cite this

+ View Abstract

Erben P, Horisberger K, Muessle B, Müller MC, Treschl A, Ernst T, Kähler G, Ströbel P, Wenz F, Kienle P, Post S, Hochhaus A, Willeke F, and Hofheinz RD

International journal of radiation oncology, biology, physics 72(5):1544-50, 2008 Dec 1 - Who cited this? | PubMed ID: 19028276 | Fulltext

Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome - a phase-II study.

+ cite this

+ View Abstract

Metzgeroth G, Walz C, Erben P, Popp H, Schmitt-Graeff A, Haferlach C, Fabarius A, Schnittger S, Grimwade D, Cross NC, Hehlmann R, Hochhaus A, and Reiter A

British journal of haematology 143(5):707-15, 2008 Dec - Who cited this? | PubMed ID: 18950453 | Fulltext

ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in CML patients.

+ cite this

+ View Abstract

Ernst T, Hoffmann J, Erben P, Hanfstein B, Leitner A, Hehlmann R, Hochhaus A, and Müller MC

Haematologica, 2008 Jul 4 - Who cited this? | PubMed ID: 18603549 | Fulltext

Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia patients treated with nilotinib.

+ cite this

+ View Abstract

La Rosée P, Holm-Eriksen S, Konig H, Härtel N, Ernst T, Debatin J, Mueller MC, Erben P, Binckebanck A, Wunderle L, Shou Y, Dugan M, Hehlmann R, Ottmann OG, and Hochhaus A

Haematologica 93(5):765, 2008 May - Who cited this? | PubMed ID: 18367481 | Fulltext

Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinib.

+ cite this

+ View Abstract

Ernst T, Erben P, Müller MC, Paschka P, Schenk T, Hoffmann J, Kreil S, La Rosée P, Hehlmann R, and Hochhaus A

Haematologica 93(2):186, 2008 Feb - Who cited this? | PubMed ID: 18223278 | Fulltext

Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories.

+ cite this

+ View Abstract

Müller MC, Erben P, Saglio G, Gottardi E, Nyvold CG, Schenk T, Ernst T, Lauber S, Kruth J, Hehlmann R, Hochhaus A, and

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 22(1):96, 2008 Jan - Who cited this? | PubMed ID: 17943168 | Fulltext

Suitability of the PAXgene system to stabilize bone marrow RNA in imatinib-resistant patients with chronic myeloid leukemia.

+ cite this

+ View Abstract

Ernst T, Hoffmann J, Erben P, Hehlmann R, Hochhaus A, and Müller MC

Clinical chemistry and laboratory medicine : CCLM / FESCC 46(3):318, 2008 - Who cited this? | PubMed ID: 18303987 | Fulltext

Expression of the p210BCR-ABL oncoprotein drives centrosomal hypertrophy and clonal evolution in human U937 cells.

+ cite this

+ View Abstract

Giehl M, Fabarius A, Frank O, Erben P, Zheng C, Hafner M, Hochhaus A, Hehlmann R, and Seifarth W

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 21(9):1971, 2007 Sep - Who cited this? | PubMed ID: 17597804 | Fulltext

JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia.

+ cite this

Krämer A, Reiter A, Kruth J, Erben P, Hochhaus A, Müller M, Cross NC, Jones AV, Ho AD, and Hensel M

The lancet oncology 8(7):658, 2007 Jul - Who cited this? | PubMed ID: 17613428 | Fulltext

Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma.

+ cite this

+ View Abstract

Metzgeroth G, Walz C, Score J, Siebert R, Schnittger S, Haferlach C, Popp H, Haferlach T, Erben P, Mix J, Müller MC, Beneke H, Müller L, Del Valle F, Aulitzky WE, Wittkowsky G,

(show remaining authors)

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 21(6):1183, 2007 Jun - Who cited this? | PubMed ID: 17377585 | Fulltext

Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses.

+ cite this

+ View Abstract

Utikal J, Ugurel S, Kurzen H, Erben P, Reiter A, Hochhaus A, Nebe T, Hildenbrand R, Haberkorn U, Goerdt S, and Schadendorf D

Archives of dermatology 143(6):736, 2007 Jun - Who cited this? | PubMed ID: 17576939 | Fulltext

Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib failure.

+ cite this

+ View Abstract

Fabarius A, Haferlach C, Müller MC, Erben P, Lahaye T, Giehl M, Frank O, Seifarth W, Hehlmann R, and Hochhaus A

Haematologica 92(6):834, 2007 Jun - Who cited this? | PubMed ID: 17550857 | Fulltext

Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia.

+ cite this

+ View Abstract

Jovanovic JV, Score J, Waghorn K, Cilloni D, Gottardi E, Metzgeroth G, Erben P, Popp H, Walz C, Hochhaus A, Roche-Lestienne C, Preudhomme C, Solomon E, Apperley J, Rondoni M, Ottaviani E,

(show remaining authors)

Blood 109(11):4635, 2007 Jun 1 - Who cited this? | PubMed ID: 17299092 | Fulltext

Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis.

+ cite this

+ View Abstract

Cortes J, Rousselot P, Kim DW, Ritchie E, Hamerschlak N, Coutre S, Hochhaus A, Guilhot F, Saglio G, Apperley J, Ottmann O, Shah N, Erben P, Branford S, Agarwal P, Gollerkeri A,

(show remaining authors)

Blood 109(8):3207-13, 2007 Apr 15 - Who cited this? | PubMed ID: 17185463 | Fulltext

Adaptive secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR/ABL+ progenitors via JAK-2/STAT-5 pathway activation.

+ cite this

+ View Abstract

Wang Y, Cai D, Brendel C, Barett C, Erben P, Manley PW, Hochhaus A, Neubauer A, and Burchert A

Blood 109(5):2147-55, 2007 Mar 1 - Who cited this? | PubMed ID: 17090651 | Fulltext

Resistance to targeted therapy in chronic myelogenous leukemia.

+ cite this

+ View Abstract

Hochhaus A, Erben P, Ernst T, and Mueller MC

Seminars in hematology 44(1 Suppl 1), 2007 Jan - Who cited this? | PubMed ID: 17292737 | Fulltext

Systemic mastocytosis simulating osseous metastatic disease.

+ cite this

Metzgeroth G, Dinter D, Erben P, La Rosée P, Hehlmann R, and Hastka J

British journal of haematology 136(1):1, 2007 Jan - Who cited this? | PubMed ID: 17222193 | Fulltext

Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion gene.

+ cite this

+ View Abstract

Walz C, Curtis C, Schnittger S, Schultheis B, Metzgeroth G, Schoch C, Lengfelder E, Erben P, Müller MC, Haferlach T, Hochhaus A, Hehlmann R, Cross NC, and Reiter A

Genes, chromosomes & cancer 45(10):950-6, 2006 Oct - Who cited this? | PubMed ID: 16845659 | Fulltext

Acoustic energy: a new transfection method for cancer of the prostate, cancer of the bladder and benign kidney cells.

+ cite this

+ View Abstract

Michel MS, Erben P, Trojan L, Schaaf A, Kiknavelidze K, Knoll T, and Alken P

Anticancer research 24(4):2303-8, 2004 - Who cited this? | PubMed ID: 15330176 | Fulltext

Prostate cancer transfection by acoustic energy using pEGFP-N1 as reporter gene in the solid Dunning R-3327-MatLu tumor.

+ cite this

+ View Abstract

Michel MS, Erben P, Trojan L, Knoll T, and Alken P

Prostate cancer and prostatic diseases 6(4):290, 2003 - Who cited this? | PubMed ID: 14663469 | Fulltext

Search Google Scholar for Erben P

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.